MAD-ID SCIENTIFIC COMMITTEE
John A. Bosso, PharmD, FCCP, FIDSA, FIDP
Department of Clinical Pharmacy
College of Pharmacy, and
Professor of Medicine
Division of Infectious Disease
College of Medicine
Medical University of South Carolina
Click to view Dr. Bosso's biography
His research interests focus on anti-infective pharmacokinetics, pharmacodynamics, and efficacy in both pediatric and adult patients. Dr. Bosso has published over 140 peer-reviewed articles in journals such as Pharmacotherapy, Antimicrobial Agents and Chemotherapy, The Journal of Infectious Diseases, The Pediatric Infectious Disease Journal, Diagnostic Microbiology and Infectious Disease, Clinical Infectious Diseases, and The Journal of Infectious Diseases Pharmacotherapy. He has written chapters for textbooks that include Pharmacotherapy: A Pathophysiologic Approach, The Pharmacotherapy Self-Assessment Program, and The Textbook of Pediatric Infectious Diseases. He has served as a member of the editorial boards of Antimicrobial Agents and Chemotherapy, Pharmacotherapy, and The Journal of Pediatric Pharmacology and Therapeutics and if currently a Scientific Editor for Pharmacotherapy.
Dr. Bosso has been active in a number of professional organizations, and was a founding member and a past-president of the Society of Infectious Diseases Pharmacists, a founding member and current president of MAD-ID is a past-president of the American College of Clinical Pharmacy.
Eileen Carter, PhD, RN
Assistant Professor of Nursing
Columbia School of Nursing and
New York – Presbyterian Hospital
New York, NY
Click to view Dr. Carter's biography
Dr. Carter received the Mary Fay Enrichment Award at Brigham and Women’s Hospital in 2009 and was named Jonas Nurse Leader Scholar at Columbia University School of Nursing 2012-2014. She has served on the National Institutes of Health, Healthcare Delivery and Methodologies, Special Emphasis Panel (July 2016) and the Centers for Disease Control and Prevention, Research on Technical Improvement of Personal Protective Equipment, Special Emphasis Panel (March 2016). Her research is funded by the Agency for Healthcare Research and Quality and she currently serves as co-investigator on two Agency grants. She recently served as a co-author on the CDC – American Nurses Association white paper entitled: Redefining the Antibiotic Stewardship Team: Recommendations from the American Nurses Association/Centers for Disease Control and Prevention Workgroup on the Role of Registered Nurses in Hospital Antibiotic Stewardship Practices.
Susan L. Davis, PharmD
Eugene Applebaum College of Pharmacy and Health Sciences
Wayne State University, and
Infectious Diseases Pharmacy Specialist
Henry Ford Hospital
Click to view Dr. Davis' biography
Her primary research interests include strategies to improve outcomes of infectious diseases with a focus on antimicrobial stewardship and multidrug resistant bacteria. Her practice, teaching and research have been recognized with the Society of Infectious Disease Pharmacists Outstanding Clinical Practice award, the American Society of Health System Pharmacists Foundation New Preceptor of the Year award, and the Wayne State University College of Pharmacy and Health Sciences Research Excellence Award. She is a board member-at-large of SIDP and has been active in MAD-ID for over 10 years.
Debra A. Goff, PharmD, FCCP
Infectious Disease Specialist
Clinical Associate Professor
The Ohio State University Medical Center, Columbus, OH
Click to view Dr. Goff's biography
Debra Goff is an Infectious Disease Specialist and founding member of the Antimicrobial Stewardship Program at The Ohio State University Wexner Medical Center (OSUWMC) in Columbus Ohio. She is the past-Director of the Infectious Diseases Residency program at OSUWMC and an Associate Professor at the College of Pharmacy working with the One Health Antibiotic Stewardship team at OSU. Dr. Goff received her Bachelor of Pharmacy and Doctor of Pharmacy degrees from the University of Illinois at Chicago, where she also completed her residency.
Dr. Goff is a 2016 TEDx Columbus speaker on antibiotics “just in case” there’s infection with over 16,500 views on YouTube. She is the international advisor to the Federation of Infectious Diseases Society of South Africa (FIDSSA) mentoring South African pharmacists. She received the 2016 OSU Emerging International Outreach and Engagement Award and the 2019 Distinguished International Outreach and Engagement Award for her work in South Africa. She is the 2017 American College of Clinical Pharmacy (ACCP) recipient of the Global Health Award. She serves as a faculty mentor to young African leaders as part of the Mandela Washington Fellowship Program. Dr. Goff is a faculty member of the World Health Organization (WHO) developing an antimicrobial stewardship toolkit for low middle income countries. She uses Twitter to engage, connect, and educate her 6,000 followers from multiple countries on issues related to antimicrobial resistance and stewardship.
Her interests include antimicrobial resistance, the application of rapid diagnostic tests with stewardship interventions, use of Twitter to increase global engagement and patient advocate organizations in antibiotic stewardship. She lectures nationally and internationally as an antimicrobial stewardship advocate.
Keith S. Kaye, MD, MPH, FIDSA, FSHEA, FACP
Professor of Internal Medicine
Director of Clinical Research, Division of Infectious Diseases
University of Michigan Medical School
Ann Arbor, MI
Click to view Dr. Kaye's biography
Dr. Kaye is a Professor of Medicine in the Department of Internal Medicine at University of Michigan Medical School. He is the Director of Research for the Division of Infectious Diseases. Dr. Kaye’s particular academic interests include the prevention and management of healthcare-associated infections including those due to multi-drug resistant pathogens; antimicrobial stewardship; and infections in the older adults.
Dr. Kaye completed his Internal Medicine residency and Infectious Diseases fellowship at Beth Israel Deaconess Medical Center in Boston, MA and earned a Masters in Public Health from the Harvard School of Public Health. Dr. Kaye has authored over 250 peer-reviewed articles and 18 book chapters and has presented original research internationally. He has dedicated his career to infection prevention and antimicrobial stewardship and is recognized internationally as an expert in healthcare epidemiology and antimicrobial resistance. He is currently serving as Past President of the Society for Health Epidemiology of America (SHEA). He is the PI on 2 NIH-funded trials evaluating the treatment of infections due to multi-drug resistant (MDR) Gram-negative bacteria with polymyxins. Dr. Kaye also conducts cutting edge research pertaining to infection prevention, and is currently the PI on an AHRQ-funded trial evaluating the impact UV disinfection of patient rooms on the acquisition of infection due to Clostridium difficile and MDR pathogens in hospitals.
Kerry L. LaPlante, PharmD., FCCP, FIDSA
Professor of Pharmacy, University of Rhode Island, Kingston, RI
Adjunct Professor of Medicine, Brown University, Providence, RI
Click to view Dr. LaPlante's biography
Kerry LaPlante, Pharm.D., FCCP is a tenured Professor of Pharmacy at the University of Rhode Island, an Adjunct Professor of Medicine at Brown University, and the Founding Director of the Antimicrobial Stewardship Research Fellowship at the Providence Veterans Medical Center. Her work is dedicated to furthering antibiotic education and research across the full spectrum of healthcare science, from antibiotic development to clinical applications. An underlying hypothesis in Dr. LaPlante’s research is that implementing positive change in prescriber habits will occur through communication, trust, personalized education, and highlighting the safety and public health benefit to their patients and their local community. Most recently, her research has focused on the development of public health messaging and trust in desperate patient populations, along with implementing antimicrobial stewardship programs in acute care, and long-term care patient populations across the VA nationally.
Dr. LaPlante’s clinical and research career has been focused on identifying effective and safe treatments for antimicrobial resistance pathogens and, more specifically on the impact that antimicrobial prescribing and stewardship has on the emergence and spread of antimicrobial resistance. Dr. LaPlante also directs active in vitro research program (BSL-2) that explores pharmacodynamic dosing indexes of combination antibiotic therapy in pathogenic bacteria, specifically the treatment, virulence inhibition (toxin and biofilm), colonization and control of multiply drug resistant pathogens in catheter lock solutions.
Dr. LaPlante has maintained continuous uninterrupted funding for her in vitro and outcomes research program from both public and private sources since arriving at the university in 2004. Her award-funding total is over 12 million from agencies such as National Institutes of Health, Department of Veterans Affairs, and Investigator Initiated Research at Pfizer, Merck and other Research and Development based pharmaceutical companies.
An internationally recognized leader in the field of antibiotic research, Dr. LaPlante is an elected Fellow of the American College of Clinical Pharmacy, and president-elect of the Society of Infectious Diseases Pharmacists, and appointed Vice-Chairperson of the Rhode Island Department of Health Antimicrobial Stewardship and Environmental Cleaning Task Force, and has served on the editorial boards for the leading journals in pharmacy and pathogenic microbiology (including Pharmacotherapy and Virulence). She is also the recipient of the Rhode Island Society of Health-System Pharmacists, 2016 Pharmacist of the Year and the Society of Infectious Diseases Pharmacist Researcher of the year 2010. She is frequently invited to lecture at national infectious diseases meetings and symposia, and is an author on over 80 peer-reviewed articles, and book chapters, which span topics from antimicrobial stewardship, antibiotic resistance, drug discovery and in vitro activity of combination antimicrobial agents. She is also the senior editor of a book titled “Antimicrobial Stewardship Principles and Practices” which is currently in press and available at Amazon.
Jason Newland, MD, EdD
Associate Professor of Pediatrics
Washington University School of Medicine in St. Louis, MO
Click to view Dr. Newland's biography
Dr. Newland grew up in southwest Oklahoma and obtained his B.S. in Pre-professional studies at the University of Notre Dame in 1996 and medical degree from the University of Oklahoma College of Medicine in 2000. He completed pediatric residency at the University of Nebraska/Creighton Medical Centers in 2003 and fellowship in Pediatric infectious diseases at the Children’s Hospital of Philadelphia in 2006, distinguishing himself with teaching awards at both the resident and fellow level.
In August of 2006, he joined the faculty at Children’s Mercy Hospitals & Clinics in Kansas City, Missouri where he was the director of the antimicrobial stewardship program and the director of evidence-based practice. An active resident and faculty mentor, he has also completed his master’s in education through a joint program offered by the Cincinnati Children’s Hospital Medical Center and the University of Cincinnati College of Education, focusing on adult learning, curriculum and teaching methods, and medical education evaluation and research. He is currently Professor of Pediatrics at Washington University School of Medicine in St. Louis.
His current research spotlights the use of antimicrobials and the impact of an antimicrobial stewardship program at a children’s hospital. He is a co-founder of the Sharing Antimicrobial Reports for Pediatric Stewardship (SHARPS) Collaborative for improving antimicrobial use in children that is comprised of over 60 Children’s Hospitals in the United States. He is the Chair of the Pediatric Infectious Diseases Society’s (PIDS) Committee on Antimicrobial Stewardship and a member of the PIDS Board of Directors.
Michael J. Rybak, PharmD, MPH, PhD, FCCP
Associate Dean for Research
Professor of Pharmacy and Medicine
Director, Anti-Infective Research Laboratory
Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI
Click to view Dr. Rybak's biography
Michael J. Rybak, Pharm.D., M.P.H., PH.D. is a Professor of Pharmacy, Department of Pharmacy Practice, adjunct Professor of Pharmaceutical Sciences and Director, Anti-Infective Research Laboratory, Eugene Applebaum College of Pharmacy & Health Sciences, Wayne State University. He is also an adjunct Professor of Medicine, Division of Infectious Diseases, School of Medicine, Wayne State University and adjunct Professor of Pharmacy-Clinical, College of Pharmacy, University of Michigan.
Over the course of a long and distinguished career at Wayne State University, he has held several important posts, including serving for nearly 33 years as the Director for the Research Fellowship Program in Infectious Diseases Pharmacotherapy and Health Outcomes as well as the Associate Dean for Research at the Eugene Applebaum College of Pharmacy and Health Sciences, Chair and member of the University’s Human Investigation Committee, the College of Pharmacy and Health Science’s research committee and Wayne State University’s Clinical Translational Research Committee.
Dr. Rybak’s primary focus of research is antimicrobial pharmacokinetics and pharmacodynamics (PK/PD) and the assessment of infectious diseases health outcomes including their relationship to bacterial resistance. His work is focused on the laboratory and clinical outcomes assessment of combination therapy for methicillin and vancomycin-resistant Staphylococcus aureus, enterococcus and multi-drug resistant gram-negative pathogens. Currently his laboratory is exploring the role of combination bacteriophage and antibiotics for the treatment of multi-drug resistant pathogens. Dr. Rybak is currently funded by the National Institute for Allergy and Infectious Diseases (NIAID), the and via several investigator initiated grants from Pharmaceutical industry. He has published more than 380 manuscripts in medical and scientific journals and authored 20 book chapters on antimicrobial PKPD, resistance and antimicrobial stewardship. He is the editor-in-chief of the journal Infectious Diseases and Therapyand a scientific editor for Infectious Diseases for Pharmacotherapy,editorial board member for Critical Reviews in Microbiology. He is a reviewer for several leading publications including Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, Open Forum Infectious Diseases and Lancet ID.
Dr. Rybak is one of the founding members, past president and fellow of the Society of Infectious Diseases Pharmacists and has held key positions at the American College of Clinical Pharmacy and the American Society of Health-Systems Pharmacists. He is a member and fellow of the Infectious Diseases Society of America and has served on key Infectious Diseases Guidelines Committees such as the MRSA guidelines committee for Infectious Diseases Society of America, the American Heart Association’s Infective Endocarditis guidelines and the Vancomycin Consensus Guidelines committee (chair).
Edward J. Septimus, MD, FIDSA, FACP, FSHEA
Texas A&M Medical School
Click to view Dr. Septimus' biography
Dr. Ed Septimus received his medical degree from Baylor College of Medicine in Houston in 1972. Dr. Septimus went on to complete his postgraduate training in internal medicine and infectious diseases at Baylor College of Medicine in Houston. Dr. Ed Septimus is board certified in both internal medicine and infectious diseases.
He was VP Research and Infectious Diseases HCA Healthcare until 2018. He has served on the Board of Directors of the Infectious Diseases Society of America (IDSA) and was on the IDSA Antimicrobial Resistance Committee, the SHEA Antimicrobial Stewardship Committee, and the IDSA Quality Measurement Committee. He was the first recipient of the IDSA Annual Clinician Award. In 2011 he was appointed to the Healthcare-Associated Infections/Preventable Adverse Events Advisory Panel for the Texas Department of State Health Services. He was awarded the John S Dunn Sr. Outstanding Teacher Award in 2010, 2011, 2013 and 2014. He is on the FDA Anti-Infective Drug Advisory Group and is co-chair of the NQF Patient Safety Steering Committee.
He holds a faculty position as Clinical Professor at Texas A&M College of Medicine, Senior Lecturer Department of Population Medicine Harvard Medical School, and Professor Distinguished Senior Fellow, School of Public Health, George Mason University. He has published over 100 articles and chapters.